Polymorphs, salts, and cocrystals: what’s in a name? S Aitipamula, R Banerjee, AK Bansal, K Biradha, ML Cheney, ... Crystal growth & design 12 (5), 2147-2152, 2012 | 1047 | 2012 |
Pharmaceutical cocrystals: along the path to improved medicines NK Duggirala, ML Perry, Ö Almarsson, MJ Zaworotko Chemical communications 52 (4), 640-655, 2016 | 920 | 2016 |
Coformer selection in pharmaceutical cocrystal development: a case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics ML Cheney, DR Weyna, N Shan, M Hanna, L Wojtas, MJ Zaworotko Journal of pharmaceutical sciences 100 (6), 2172-2181, 2011 | 273 | 2011 |
Effects of crystal form on solubility and pharmacokinetics: a crystal engineering case study of lamotrigine ML Cheney, N Shan, ER Healey, M Hanna, L Wojtas, MJ Zaworotko, ... Crystal Growth & Design 10 (1), 394-405, 2010 | 270 | 2010 |
Supramolecular architectures of meloxicam carboxylic acid cocrystals, a crystal engineering case study ML Cheney, DR Weyna, N Shan, M Hanna, L Wojtas, MJ Zaworotko Crystal growth & design 10 (10), 4401-4413, 2010 | 147 | 2010 |
Improving solubility and pharmacokinetics of meloxicam via multiple-component crystal formation DR Weyna, ML Cheney, N Shan, M Hanna, MJ Zaworotko, V Sava, ... Molecular pharmaceutics 9 (7), 2094-2102, 2012 | 145 | 2012 |
Impact of pharmaceutical cocrystals: the effects on drug pharmacokinetics N Shan, ML Perry, DR Weyna, MJ Zaworotko Expert opinion on drug metabolism & toxicology 10 (9), 1255-1271, 2014 | 143 | 2014 |
Crystallization method and bioavailability M Hanna, N Shan, M Cheney, D Weyna, RK Houck US Patent 8,399,023, 2013 | 117 | 2013 |
Oral forms of a phosphonic acid derivative M Hanna, N Shan, M Cheney, D Weyna US Patent 8,980,868, 2015 | 109 | 2015 |
Oral forms of a phosphonic acid derivative M Hanna, N Shan, M Cheney, D Weyna US Patent 8,980,868, 2015 | 109 | 2015 |
Oral forms of a phosphonic acid derivative M Hanna, N Shan, M Cheney, D Weyna US Patent 8,980,868, 2015 | 109 | 2015 |
The role of cocrystals in solid-state synthesis: cocrystal-controlled solid-state synthesis of imides ML Cheney, GJ McManus, JA Perman, Z Wang, MJ Zaworotko Crystal growth & design 7 (4), 616-617, 2007 | 97 | 2007 |
In vivo studies of crystalline forms of meloxicam M Hanna, N Shan, ML Cheney, DR Weyna US Patent 8,124,603, 2012 | 96 | 2012 |
In vivo studies of crystalline forms of meloxicam M Hanna, N Shan, ML Cheney, DR Weyna US Patent 8,124,603, 2012 | 96 | 2012 |
In vivo studies of crystalline forms of meloxicam M Hanna, N Shan, ML Cheney, DR Weyna US Patent 8,124,603, 2012 | 96 | 2012 |
In vivo studies of crystalline forms of meloxicam M Hanna, N Shan, ML Cheney, DR Weyna US Patent 8,124,603, 2012 | 96 | 2012 |
In vivo studies of crystalline forms of meloxicam M Hanna, N Shan, ML Cheney, DR Weyna US Patent 8,124,603, 2012 | 96 | 2012 |
Crystallization method and bioavailability M Hanna, N Shan, ML Cheney, DR Weyna, RK Houck US Patent 8,933,057, 2015 | 89 | 2015 |
Crystallization method and bioavailability M Hanna, N Shan, ML Cheney, DR Weyna, R Houck US Patent 9,169,279, 2015 | 85 | 2015 |
Crystallization method and bioavailability M Hanna, N Shan, ML Cheney, DR Weyna, R Houck US Patent 9,169,279, 2015 | 84 | 2015 |